Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-02-09 @ 3:39 PM
Study NCT ID:
NCT01234857
Status:
COMPLETED
Last Update Posted:
2017-05-31
First Post:
2010-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
Sponsor:
Organization: